Faraj Janine, Takanti Varun, Tavakoli Hamid R
is a General Medical Officer at Naval Surface Forces Atlantic, Medical Readiness Division, Norfolk, Virginia. is a Resident Physician in the Department of Anesthesiology at Rush University Hospital in Chicago, Illinois. is the head of Psychiatry Consultation-Liaison Services at the Naval Medical Center, Portsmouth, Virginia.
Fed Pract. 2021 Aug;38(8):356-362. doi: 10.12788/fp.0159.
Literature exploring the relationship between the intestinal microbiome and its effects on general health and well-being has grown significantly in recent years, and our knowledge of this subject continues to grow. Mounting evidence indicates that the intestinal microbiome is a potential target for therapeutic intervention in psychiatric illness and in neurodegenerative disorders such as Alzheimer disease. It is reasonable to consider modulating not just a patient's neurochemistry, behavior, or cognitive habits, but also their intestinal microbiome in an effort to improve psychiatric symptoms.
In this review paper, we show that intestinal microbiota possess the ability to directly influence both physical and mental well-being; therefore, should be included in future discussions regarding psychiatric treatment.
Clinicians are encouraged to consider patients' gut health when evaluating and treating psychiatric conditions, such as anxiety and depression. Optimization and diversification of gut flora through the use of psychobiotics-probiotics that confer mental health benefits-may soon become standard practice in conjunction with traditional psychiatric treatment modalities such as pharmacotherapy and psychotherapy.
近年来,探索肠道微生物群及其对总体健康和幸福感影响之间关系的文献显著增加,我们对这一主题的了解也在不断加深。越来越多的证据表明,肠道微生物群是精神疾病和神经退行性疾病(如阿尔茨海默病)治疗干预的潜在靶点。合理的做法是不仅考虑调节患者的神经化学、行为或认知习惯,还考虑调节他们的肠道微生物群,以改善精神症状。
在这篇综述论文中,我们表明肠道微生物群具有直接影响身心健康的能力;因此,应纳入未来关于精神治疗的讨论中。
鼓励临床医生在评估和治疗焦虑和抑郁等精神疾病时考虑患者的肠道健康。通过使用具有心理健康益处的精神益生菌(益生菌)来优化和多样化肠道菌群,可能很快会与药物治疗和心理治疗等传统精神治疗方式一起成为标准做法。